SCHEMBL1389819

SCHEMBL1389819

Cc1cc(C(CC(c2ccc(-c3ccc(C(=O)O)cc3)cc2)c2ccc(Cl)cc2F)=NO)ccn1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 5/20 0.69
▸ PSEN1 P49768 1/20 0.36
▸ PSEN2 P49810 1/20 0.36
▸ APH1B Q8WW43 1/20 0.36
▸ NCSTN Q92542 1/20 0.36
▸ APH1A Q96BI3 1/20 0.36
▸ PSENEN Q9NZ42 1/20 0.36
▸ F11 P03951 1/20 0.35
▸ PRCP P42785 1/20 0.35
▸ KDM5A P29375 2/20 0.34
▸ KDM5B Q9UGL1 2/20 0.34
▸ S1PR1 P21453 1/20 0.34
▸ S1PR3 Q99500 1/20 0.34
▸ KDM4C Q9H3R0 3/20 0.33
▸ MAPKAPK2 P49137 1/20 0.33
▸ SRD5A2 P31213 1/20 0.33
▸ CTSA P10619 1/20 0.33
▸ KMO O15229 3/20 0.32
▸ MAP4K4 O95819 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL362770 1.00 GPBAR1 (0.69) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL1389844 0.92 GPBAR1 (0.61) GPBAR1KDM5AKDM5BS1PR1S1PR3
SCHEMBL364258 0.92 GPBAR1 (0.61) GPBAR1KDM5AKDM5BS1PR1S1PR3
SCHEMBL1389847 0.92 GPBAR1 (0.61) GPBAR1KDM5AKDM5BS1PR1S1PR3
SCHEMBL1390008 0.91 GPBAR1 (0.58) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL362306 0.91 GPBAR1 (0.58) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL1389974 0.91 GPBAR1 (0.58) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL1390482 0.91 GPBAR1 (0.58) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL364252 0.91 GPBAR1 (0.58) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL1389712 0.91 GPBAR1 (0.58) GPBAR1PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 — — EP claimed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 — — US claimed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 — — US claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 — — EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 — — US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885PSEN1 663/4885PSEN2 1754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback